399 related articles for article (PubMed ID: 17109390)
1. The effect of budesonide mouthwash on oral chronic graft versus host disease.
Sari I; Altuntas F; Kocyigit I; Sisman Y; Eser B; Unal A; Fen T; Ferahbas A; Ozturk A; Unal A; Cetin M
Am J Hematol; 2007 May; 82(5):349-56. PubMed ID: 17109390
[TBL] [Abstract][Full Text] [Related]
2. Enteral budesonide in treatment for mild and moderate gastrointestinal chronic GVHD.
Andree H; Hilgendorf I; Leithaeuser M; Junghanss C; Holzhueter S; Loddenkemper C; Steiner B; Freund M; Wolff D
Bone Marrow Transplant; 2008 Oct; 42(8):541-6. PubMed ID: 18641680
[TBL] [Abstract][Full Text] [Related]
3. A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease.
Akpek G; Lee SM; Anders V; Vogelsang GB
Biol Blood Marrow Transplant; 2001; 7(9):495-502. PubMed ID: 11669216
[TBL] [Abstract][Full Text] [Related]
4. Comparison of budesonide and dexamethasone for local treatment of oral chronic graft-versus-host disease.
Park AR; La HO; Cho BS; Kim SJ; Lee BK; Rhie JY; Gwak HS
Am J Health Syst Pharm; 2013 Aug; 70(16):1383-91. PubMed ID: 23903476
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamic action of budesonide after buccal administration in healthy subjects and patients with oral chronic graft-versus-host disease.
Dilger K; Halter J; Bertz H; Lopez-Lazaro L; Gratwohl A; Finke J
Biol Blood Marrow Transplant; 2009 Mar; 15(3):336-43. PubMed ID: 19203724
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis of graft-versus-host disease with cyclosporine-prednisone is associated with increased risk of chronic graft-versus-host disease.
Kumar S; Chen MG; Gastineau DA; Gertz MA; Inwards DJ; Lacy MQ; Tefferi A; Harmsen WS; Litzow MR
Bone Marrow Transplant; 2001 Jun; 27(11):1133-40. PubMed ID: 11551023
[TBL] [Abstract][Full Text] [Related]
7. Budesonide: a novel treatment for oral chronic graft versus host disease.
Elad S; Or R; Garfunkel AA; Shapira MY
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Mar; 95(3):308-11. PubMed ID: 12627101
[TBL] [Abstract][Full Text] [Related]
8. Improvement in oral chronic graft-versus-host disease with the administration of effervescent tablets of topical budesonide-an open, randomized, multicenter study.
Elad S; Zeevi I; Finke J; Koldehoff M; Schwerdtfeger R; Wolff D; Mohrbacher R; Levitt M; Greinwald R; Shapira MY
Biol Blood Marrow Transplant; 2012 Jan; 18(1):134-40. PubMed ID: 21703973
[TBL] [Abstract][Full Text] [Related]
9. First-line therapy for chronic graft-versus-host disease that includes low-dose methotrexate is associated with a high response rate.
Wang Y; Xu LP; Liu DH; Chen H; Chen YH; Han W; Liu KY; Huang XJ
Biol Blood Marrow Transplant; 2009 Apr; 15(4):505-11. PubMed ID: 19285639
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease.
Jurado M; Vallejo C; Pérez-Simón JA; Brunet S; Ferra C; Balsalobre P; Pérez-Oteyza J; Espigado I; Romero A; Caballero D; Sierra J; Ribera JM; Díez JL
Biol Blood Marrow Transplant; 2007 Jun; 13(6):701-6. PubMed ID: 17531780
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of oral chronic graft-versus-host disease.
Treister NS; Cook EF; Antin J; Lee SJ; Soiffer R; Woo SB
Biol Blood Marrow Transplant; 2008 Jan; 14(1):110-5. PubMed ID: 18158967
[TBL] [Abstract][Full Text] [Related]
13. Consensus conference on clinical practice in chronic graft-versus-host disease (GVHD): first-line and topical treatment of chronic GVHD.
Wolff D; Gerbitz A; Ayuk F; Kiani A; Hildebrandt GC; Vogelsang GB; Elad S; Lawitschka A; Socie G; Pavletic SZ; Holler E; Greinix H
Biol Blood Marrow Transplant; 2010 Dec; 16(12):1611-28. PubMed ID: 20601036
[TBL] [Abstract][Full Text] [Related]
14. How can we help patients with refractory chronic graft versus host disease- single centre experience.
Rzepecki P; Barzal J; Sarosiek T; Oborska S; Szczylik C
Neoplasma; 2007; 54(5):431-6. PubMed ID: 17688373
[TBL] [Abstract][Full Text] [Related]
15. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.
Ilhan O; Arat M; Arslan O; Ayyildiz E; Sanli H; Beksac M; Ozcan M; Gürman G; Akan H
Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621
[TBL] [Abstract][Full Text] [Related]
16. Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease.
Wolff D; Anders V; Corio R; Horn T; Morison WL; Farmer E; Vogelsang GB
Photodermatol Photoimmunol Photomed; 2004 Aug; 20(4):184-90. PubMed ID: 15238096
[TBL] [Abstract][Full Text] [Related]
17. Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
Lanino E; Rondelli R; Locatelli F; Messina C; Pession A; Balduzzi A; Favre C; Santarone S; Rabusin M; Pollichieni S; Cesaro S; Dini G;
Biol Blood Marrow Transplant; 2009 Jun; 15(6):741-8. PubMed ID: 19450759
[TBL] [Abstract][Full Text] [Related]
18. Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases.
Epstein JB; Gorsky M; Epstein MS; Nantel S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jan; 91(1):56-61. PubMed ID: 11174572
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Busca A; Locatelli F; Marmont F; Ceretto C; Falda M
Am J Hematol; 2007 Jan; 82(1):45-52. PubMed ID: 16937391
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease.
Johnston LJ; Brown J; Shizuru JA; Stockerl-Goldstein KE; Stuart MJ; Blume KG; Negrin RS; Chao NJ
Biol Blood Marrow Transplant; 2005 Jan; 11(1):47-55. PubMed ID: 15625544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
